Join to View Full Profile
100 Blossom StHematology Oncology Associates Cox 2Boston, MA 02114
Phone+1 617-724-3200
Fax+1 617-726-2894
Dr. Boussiotis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UMass Chan Medical SchoolResidency, Internal Medicine, 2004 - 2004
University of AthensClass of 1982
Certifications & Licensure
MA State Medical License 2004 - 2026
Clinical Trials
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML) Start of enrollment: 2011 Sep 01
Publications & Presentations
PubMed
- Same-Slide Spatial Multi-Omics Integration Reveals Tumor Virus-Linked Spatial Reorganization of the Tumor Microenvironment.Yao Yu Yeo, Yuzhou Chang, Huaying Qiu, Stephanie Pei Tung Yiu, Hendrik A Michel
Biorxiv. 2024-12-22 - Alarm Functions of PD-1+ Brain-Resident Memory T Cells.Shawn C Musial, Sierra A Kleist, Hanna N Degefu, Myles A Ford, Tiffany Chen
Journal of Immunology. 2024-12-01 - 2 citationsEmergency myelopoiesis in solid cancers.Konstantinos Aliazis, Sasitorn Yenyuwadee, Ployploen Phikulsod, Vassiliki A Boussiotis
British Journal of Haematology. 2024-09-01
Press Mentions
NanoView Biosciences Launches EPIC Study to Investigate Impact of Exosome-Associated Biomarkers for Immuno-OncologyApril 15th, 2021- NanoView, Beth Israel Deaconess Medical Center Launch Immuno-Oncology Biomarker StudyApril 15th, 2021
- CD39+PD-1+CD8+ T Cells Mediate Metastatic Dormancy in Breast CancerFebruary 3rd, 2021
- Join now to see all
Grant Support
- Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments.BETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
- Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapyBETH ISRAEL DEACONESS MEDICAL CENTER2023–2027
- Detection of PD-1 inhibitory signaling and its molecular relays in T cells: Implications for cancer immunotherapyBETH ISRAEL DEACONESS MEDICAL CENTER2023–2027
- The effects of PD-1 on tumor-mediated “emergency” myelopoiesis and fate commitment of myeloid cells: Implications for anti-tumor immunityBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
- Prevention Of Acute GVHD By Inhibition Of CDK2National Heart, Lung, And Blood Institute2011–2012
- The Role Of RAP1 And Its Novel Associated Molecules In T Cell ResponsesNational Institute Of Allergy And Infectious Diseases2011
- The Role Of RAP1 In T-Cell ResponsesNational Institute Of Allergy And Infectious Diseases2008–2009
- Reconstitution Of T Cell Immunity After UCB Transplantation: The Role Of TregNational Cancer Institute2008–2009
- Expression And Function Of TOB In T LymphocytesNational Cancer Institute2008–2009
- The Role Of RAP1 In T-Cell ResponsesNational Institute Of Allergy And Infectious Diseases2005–2008
- Expression And Function Of TOB In T LymphocytesNational Cancer Institute2005–2007
- The Role Of RAP1 In T-Cell ResponsesNational Institute Of Allergy And Infectious Diseases2003
- The Role Of P27KIP1 In T-Cell ResponsesNational Institute Of Allergy And Infectious Diseases2001–2003
- RAP1 And Associated Molecules And T Cell AnergyNational Institute Of Allergy And Infectious Diseases1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
